http://www.dementialab.org Tue, 15 Nov 2016 15:18:53 +0000 en-US hourly 1 http://wordpress.org/?v=3.5.1 http://www.dementialab.org/phase-iii-tau-drug-fails-to-meet-endpoints-but-shows-silver-lining-as-monotherapy/ http://www.dementialab.org/phase-iii-tau-drug-fails-to-meet-endpoints-but-shows-silver-lining-as-monotherapy/#comments Wed, 27 Jul 2016 10:25:43 +0000 Robin Brisbourne http://www.dementialab.org/?p=1339 At AAIC2016, researchers from TauRx Therapeutics Ltd presented results from a phase III clinical trial of the drug leuco-methylthioninium-bis(hydromethanesulfonate) or LMTM in people with mild-to-moderate Alzheimer’s disease

]]> http://www.dementialab.org/phase-iii-tau-drug-fails-to-meet-endpoints-but-shows-silver-lining-as-monotherapy/feed/ 0 http://www.dementialab.org/researchers-unravel-a-mechanism-behind-age-related-memory-decline/ http://www.dementialab.org/researchers-unravel-a-mechanism-behind-age-related-memory-decline/#comments Thu, 29 Aug 2013 08:21:50 +0000 Laura Phipps http://www.dementialab.org/?p=744 Scientists at Columbia University in New York have outlined a molecular mechanism behind age-related memory decline.

]]> http://www.dementialab.org/researchers-unravel-a-mechanism-behind-age-related-memory-decline/feed/ 0